In conclusion, we report the detailed investigation of a truncating variant in the candidate breast and ovarian cancer susceptibility gene, MRE11A. Our findings, taken together with other recently published studies, show that truncating variants in MRE11A are not a cause of breast or ovarian cancer. The gene discussed is MRE11; the disease is ovarian cancer.